Litcius/Paper detail

FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology

Elizabeth S. Russell, Elodie Aubrun, Daniela C. Moga, Sandra Guedes, Wendy Camelo Castillo, Janet Hardy, J. Alexander Cole, Oladayo Jagun

2023Journal of Clinical and Translational Science12 citationsDOIOpen Access PDF

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Topics & Concepts

PharmacoepidemiologyClinical trialDiversity (politics)MedicineLibrary scienceComputer sciencePolitical sciencePharmacologyInternal medicineLawMedical prescriptionBiomedical Ethics and RegulationHealth and Medical Research ImpactsPharmaceutical industry and healthcare
FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology | Litcius